News & Events

Signify Research’s latest external press coverage, company news and updates on key industry events that our analysts are attending

Why best-of-breed LIS vendors might yet survive EHR’s invasion

31st May 2022 – Written by Imogen Fitt – Featured on Labpulse.com – Electronic health record (EHR) vendors are increasingly canabalizing clinical departmental IT administration, such as radiology information systems and cardiology information systems. Best-of-breed laboratory information systems (BoB-LIS) are often viewed as the next departmental IT lamb headed for the slaughter at the altar […]

Hospital Telehealth Vendor Financials Round Up – Teladoc Health, Amwell & SOC Telemed

20th May 2022 – Written by Arun Gill – Featured on HIT Consultant – Several hospital telehealth vendors enjoyed great success in 2020 as they benefitted from unprecedented demand for their IT and services during the pandemic. But as lockdown restrictions were lifted and the strain on hospitals’ in-house capacity across the ICU and other […]

Imaging AI’s Unseen Potential

24th May 2022 – Written by Amy Thompson – Featured on The Imaging Wire Amid the dozens of imaging AI papers and presentations that came out over the last few weeks were three compelling new studies highlighting how much “unseen” information AI can extract from medical images, and the massive impact this information could have. […]

Imaging IT market entering an atypical growth period

23rd May 2022 – Written by Amy Thompson – Featured on Healthcare Business Euro News – The global imaging IT market has recovered swiftly from the slight downturn experienced in 2020. A second, strong performing year in the advanced visualisation IT market was due to healthcare providers’ continued investment in modality and tools that aided […]

Will new growth stem from the 1B euro Affidea deal?

Written by Steve Holloway – Featured on AuntMinnie.com – April 26, 2022 — News of the 1-billion-euro intended acquisition of outpatient imaging provider Affidea by Belgian investment firm Groupe Bruxelles Lambert (GBL) may not be viewed by industry stalwarts as a landmark event, but it’s clear Affidea has established a modus operandi that offers substantial upside […]